ANGLE Past Earnings Performance

Past criteria checks 0/6

ANGLE's earnings have been declining at an average annual rate of -16.1%, while the Medical Equipment industry saw earnings growing at 1.9% annually. Revenues have been growing at an average rate of 24.3% per year.

Key information

-16.1%

Earnings growth rate

-4.7%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate24.3%
Return on equity-73.6%
Net Margin-890.9%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Will ANGLE (LON:AGL) Spend Its Cash Wisely?

Sep 27
Will ANGLE (LON:AGL) Spend Its Cash Wisely?

We're Keeping An Eye On ANGLE's (LON:AGL) Cash Burn Rate

Mar 20
We're Keeping An Eye On ANGLE's (LON:AGL) Cash Burn Rate

Will ANGLE (LON:AGL) Spend Its Cash Wisely?

Dec 02
Will ANGLE (LON:AGL) Spend Its Cash Wisely?

We Think ANGLE (LON:AGL) Needs To Drive Business Growth Carefully

Aug 11
We Think ANGLE (LON:AGL) Needs To Drive Business Growth Carefully

We Think ANGLE (LON:AGL) Needs To Drive Business Growth Carefully

Feb 28
We Think ANGLE (LON:AGL) Needs To Drive Business Growth Carefully

ANGLE (LON:AGL) Is In A Good Position To Deliver On Growth Plans

Jul 16
ANGLE (LON:AGL) Is In A Good Position To Deliver On Growth Plans

ANGLE (LON:AGL) Is In A Good Position To Deliver On Growth Plans

Aug 23
ANGLE (LON:AGL) Is In A Good Position To Deliver On Growth Plans

We're Not Very Worried About ANGLE's (LON:AGL) Cash Burn Rate

May 02
We're Not Very Worried About ANGLE's (LON:AGL) Cash Burn Rate

What Type Of Shareholders Make Up ANGLE plc's (LON:AGL) Share Registry?

Feb 14
What Type Of Shareholders Make Up ANGLE plc's (LON:AGL) Share Registry?

We're Keeping An Eye On ANGLE's (LON:AGL) Cash Burn Rate

Dec 22
We're Keeping An Eye On ANGLE's (LON:AGL) Cash Burn Rate

Revenue & Expenses Breakdown

How ANGLE makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

AIM:AGL Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 242-1892
31 Mar 242-19102
31 Dec 232-20112
30 Sep 232-21133
30 Jun 232-22154
31 Mar 231-22154
31 Dec 221-22144
30 Sep 221-19133
30 Jun 221-17123
31 Mar 221-16113
31 Dec 211-15103
30 Sep 211-15113
30 Jun 211-16113
31 Mar 211-1493
31 Dec 201-1273
30 Jun 201-1044
31 Mar 201-1154
31 Dec 191-1154
31 Oct 191-1072
31 Jul 191-962
30 Apr 191-952
31 Jan 191-952
31 Oct 181-852
31 Jul 181-842
30 Apr 181-842
31 Oct 170-743
31 Jul 170-743
30 Apr 170-733
31 Oct 161-560
31 Jul 160-560
30 Apr 160-560
31 Jan 160-550
31 Oct 150-450
31 Jul 150-440
30 Apr 150-440
31 Oct 14-1-340
31 Jul 140-330
30 Apr 140-220
31 Jan 142-100

Quality Earnings: AGL is currently unprofitable.

Growing Profit Margin: AGL is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AGL is unprofitable, and losses have increased over the past 5 years at a rate of 16.1% per year.

Accelerating Growth: Unable to compare AGL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AGL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (39.9%).


Return on Equity

High ROE: AGL has a negative Return on Equity (-73.58%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies